Latest filing published 23 Jun 2006 for ACCENTIA BIOPHARMACEUTICALS INC, €35k.
Insider track record
No signal scores available.
Dennis L. Ryll: trading record in brief
Dennis L. Ryll discloses dealings in Accentia Biopharmaceuticals Inc to SEC (Form 4). Between 3 April 2006 and 15 May 2006, the trades on record add up to 3 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 23 June 2006 with a transaction (€35k) in Accentia Biopharmaceuticals Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Dennis L. Ryll
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,339 shares@ US$8.00Common StockSEC:0001181431-06-038226:1
- 252 shares@ US$8.00Common StockSEC:0001181431-06-038226:0
- 412,892 shares0Common StockSEC:0001181431-06-031353:0
3 of 3 declarations